Integra Lifesciences Holdings Corp
IARTNasdaqCIK 917520HealthcareFiscal year ends Dec 31
Reports and events: 381 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:01 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000917520-26-000077 |
| 2026-10-2110:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-26-000073 |
| 2026-10-1920:20 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-425271 |
| 2026-10-0921:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-419228 |
| 2026-10-0212:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-26-000067 |
| 2026-09-0810:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-26-000061 |
| 2026-07-2920:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000917520-26-000058 |
| 2026-07-2910:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-26-000055 |
| 2026-05-0820:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000917520-26-000044 |
| 2026-05-0520:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000917520-26-000041 |
| 2026-05-0510:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000917520-26-000034 |
| 2026-05-0510:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-26-000033 |
| 2026-04-1520:24 ET | 8-K | 1.01 Entry into a material agreement | 0000917520-26-000019 |
| 2026-04-0620:43 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0000917520-26-000015 |
| 2026-02-2621:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000917520-26-000011 |
| 2026-02-2611:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-26-000008 |
| 2025-12-1221:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000917520-25-000100 |
| 2025-10-3020:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000917520-25-000096 |
| 2025-10-3010:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-25-000094 |
| 2025-07-3120:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000917520-25-000074 |
| 2025-07-3110:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-25-000069 |
| 2025-06-0910:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000917520-25-000060 |
| 2025-05-1320:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000917520-25-000052 |
| 2025-05-0520:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000917520-25-000041 |
| 2025-05-0510:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-25-000038 |
| 2025-04-0420:43 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000917520-25-000032 |
| 2025-02-2522:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000917520-25-000017 |
| 2025-02-2511:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-25-000014 |
| 2025-01-0613:00 ET | 8-K | 8.01 Other events | 0000917520-25-000004 |
| 2024-12-1721:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000917520-24-000121 |
| 2024-11-0421:09 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000917520-24-000108 |
| 2024-11-0411:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-24-000106 |
| 2024-11-0411:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-24-000105 |
| 2024-07-2920:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000917520-24-000094 |
| 2024-07-2910:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-24-000092 |
| 2024-05-1700:09 ET | 8-K | 8.01 Other events | 0000917520-24-000074 |
| 2024-05-1320:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000917520-24-000066 |
| 2024-05-0620:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000917520-24-000061 |
| 2024-05-0610:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-24-000059 |
| 2024-04-0420:39 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0000917520-24-000053 |
| 2024-02-2821:13 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000917520-24-000022 |
| 2024-02-2811:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-24-000018 |
| 2024-02-2811:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-24-000017 |
| 2024-02-2722:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000917520-24-000011 |
| 2023-12-2021:57 ET | 8-K | 1.01 Entry into a material agreement | 0000917520-23-000082 |
| 2023-12-1321:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000917520-23-000079 |
| 2023-12-1311:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-23-000077 |
| 2023-10-2520:21 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000917520-23-000071 |
| 2023-10-2510:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-23-000069 |
| 2023-08-1601:15 ET | 8-K | 8.01 Other events | 0000917520-23-000065 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.